Always starting from the patient’s perspective, we take new approaches to our clinical studies that help build a better understanding of rare disease progression and treatment.
Minimize the burden on patients and caregivers during clinical trials while also improving data quality with real-world evidence.
Understand the nuances of disease progression and treatment benefit by focusing on patient experience.
Capture the real-world impact of treatment interventions on patient quality-of-life through smarter outcome measures.
At Casimir, we combine our knowledge of living with rare disease with our experience in navigating a complex regulatory landscape to build and run clinical trials that utilize the patient experience in a way that benefits both patient and sponsor.